Wednesday, 18 November 2026LatestVideosAboutContact
Latest
Anmol Kharb vs Tomoka Miyazaki LIVE streaming info: Where to watch Hong Kong Open 2026 Round of 32 match?Mauricio Pochettino starts work at Man Utd; Liverpool first up for Red DevilsHyderabad’s Praanjala ranked ninth among India’s junior badminton playersDisney’s new Star Wars animatronics interact with guests using AIUN Sustainable Development Goals group for science, technology rejiggedMaha Minister Chandrashekhar Bawankule Urges Legislators To Use MLA, MP Funds For Drought Relief, Water Conservation & Fodder Development'Ananya Birla Was So Out Of Place': Netizens Accuse Ananya Panday & Shanaya Kapoor Of 'Mean Girl' Behaviour After Group Hug On Koffee With Karan 9Hyderabad doctor secures affordable rare disease drug for seven children with AHDSAnanya Panday Calls Rumoured Exes Aditya, Ishaan And Kartik On KWK 9, Karan Johar Reacts | WATCHRecord ocean warming hundreds of meters below B.C. coast linked to El NiñoBee-lieve it or not, bumblebees have a sweet spot for saltSoon, Waste Interceptors On Mithi River As The Ocean Cleanup Sign MoU With BMC For Nine New Sites
NationalUpdated 18 min ago

Hyderabad doctor secures affordable rare disease drug for seven children with AHDS

Image: Telangana Today

Hyderabad: In a relief for families battling rare genetic disorders, city-based paediatrician Dr Sivaranjani Santosh, alongside Access to Medicines India, is set to hand over life-saving medication to seven children suffering from Allan-Herndon-Dudley syndrome (AHDS) on November 30.

The medicine, Tiratricol, crucial for managing the rare MCT8 deficiency affecting thyroid hormone transport into brain cells, has been custom-compounded by a Netherlands-based pharmacy through the Pharmaceutical Accountability Foundation (PAF).

While commercial variants of the medicine cost an astronomical Rs 4.68 crore to Rs 9 crore annually, the compassionate batch for the children, sourced by a senior Hyderabad-based paediatrician, costs roughly Rs 2.5 lakh per child per year.

The breakthrough followed an extensive social media advocacy campaign launched by Dr Sivaranjani after her young patient, Arav, struggled to sustain monthly import costs of Rs 12 lakh to Rs 13 lakh from Germany.

The appeal caught the attention of PAF, paving the way for cost-effective pharmaceutical compounding. Beneficiaries include children under Dr Sivaranjani’s care and five patients identified at Christian Medical College (CMC), Vellore.

While individual import permits have been secured for a year, healthcare advocates said that relying on foreign imports is unsustainable. Dr Sivaranjani plans to urge the Union government to encourage domestic production, aiming to make treatment permanently affordable for all children nationwide.

This content is published by Telangana Today and has not been created or edited by Hello Headlines. View original

More in National

See all